Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/36851
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
- BA - IGM - Artigos de Periódicos [3687]
- INI - Artigos de Periódicos [3488]
- IOC - Artigos de Periódicos [12747]
Metadata
Show full item record
GLOPID-R REPORT ON CHIKUNGUNYA, O'NYONG-NYONG AND MAYARO VIRUS, PART 2: EPIDEMIOLOGICAL DISTRIBUTION OF O'NYONG-NYONG VIRUS
O'nyong-nyong Virus
História Natural das Doenças
Soroprevalência
Epidemiologia
O'nyong-nyong Virus
Natural History of Diseases
Soroprevalence
Epidemiology
Author
Pezzi, L.
LaBeaud, A. D.
Reusken, C. B.
Drexler, Jan Felix
Vasilakis, N.
Diallo, M.
Simon, F.
Jaenisch, T.
Gallian, P.
Sall, A.
Failloux, A. B.
Weaver, S. C.
Lamballerie, X. de
Boyer, S.
Brasil, Patrícia
Busch, M.
Diamond, M. S.
Drebot, M. A.
Kohl, A.
Lecuit, M.
Oliveira, Ricardo Lourenço de
Neytsy, J.
Ng, Lfp
Ribeiro, Guilherme de Sousa
Rios, M.
Rodriguez-Morales, A. J.
Freitas, Maria Goreti Rosa
Simmons, G.
Siqueira, André Machado de
Rua, A. Vega
LaBeaud, A. D.
Reusken, C. B.
Drexler, Jan Felix
Vasilakis, N.
Diallo, M.
Simon, F.
Jaenisch, T.
Gallian, P.
Sall, A.
Failloux, A. B.
Weaver, S. C.
Lamballerie, X. de
Boyer, S.
Brasil, Patrícia
Busch, M.
Diamond, M. S.
Drebot, M. A.
Kohl, A.
Lecuit, M.
Oliveira, Ricardo Lourenço de
Neytsy, J.
Ng, Lfp
Ribeiro, Guilherme de Sousa
Rios, M.
Rodriguez-Morales, A. J.
Freitas, Maria Goreti Rosa
Simmons, G.
Siqueira, André Machado de
Rua, A. Vega
Affilliation
Aix-Marseille Université. Unité des Virus Émergents. Marseille, France / Université de Corse-Inserm. Laboratoire de Virologie. Corte, France.
Stanford University. School of Medicine. Division of Infectious Diseases. Department of Pediatrics. Palo Alto, CA, USA.
National Institute for Public Health and the Environment. Centre for Infectious Disease Control. Bilthoven, The Netherlands / Erasmus University Medical Center. Department Viroscience. Rotterdam, The Netherlands.
Humboldt-Universität zu Berlin. Corporate Member of Freie Universität Berlin. Charité-Universitätsmedizin Berlin. Berlin, Germany / Berlin Institute of Health. Institute of Virology. Berlin, Germany / German Centre for Infection Research. Germany.
University of Texas. Medical Branch. Institute of Human Infection and Immunity. Department of Pathology. Galveston, TX, USA.
Institut Pasteur de Dakar. Unité D'Entomologie Médicale. Dakar, Senegal.
Laveran Military Teaching Hospital. Marseille, France.
Heidelberg University Hospital. Department of Infectious Diseases. Section Clinical Tropical Medicine. Heidelberg, Germany.
Établissement Français Du Sang Alpes Méditerranée. Marseille, France.
Institut Pasteur de Dakar. Unité D'Entomologie Médicale. Dakar, Senegal.
Institut Pasteur. Department of Virology. Arboviruses and Insect Vectors Unit. Paris, France.
University of Texas Medical Branch. Institute for Human Infections and Immunity. Department of Microbiology and Immunology. Galveston, TX, USA.
Aix-Marseille Université. Unité des Virus Émergents. Marseille, France.
Institut Pasteur Du Cambodge. Medical Entomology Platform. Phnom Penh, Cambodia.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Blood Systems Research Institute. San Francisco, CA, USA / University of California. Department of Laboratory Medicine. San Francisco, CA, USA.
Washington University. School of Medicine. Department of Medicine. Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. St. Louis, MO, USA / Washington University. School of Medicine. Department of Molecular Microbiology. Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. St. Louis, MO, USA / Washington University. School of Medicine. Department of Pathology and Immunology. Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. St. Louis, MO, USA.
Public Health Agency of Canada. National Microbiology Laboratory. Zoonotic Diseases and Special Pathogens. Winnipeg, Canada.
Medical Research Council. University of Glasgow. Centre for Virus Research. Glasgow, UK.
Institut Pasteur. Biology of Infection Unit. Inserm U1117. Paris Descartes University. Departement of Infectious Diseases and Tropical Medicine. Necker-Enfants Malades University Hospital. APHP. IHU Imagine. Paris, France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Mosquitos Transmissores de Hematozoários. Rio de Janeiro, RJ, Brasil.
Katholieke Universiteit Leuven. Rega Institute for Medical Research. Department of Microbiology and Immunology. Laboratory of Virology and Chemotherapy. Leuven, Belgium.
Singapore Immunology Network. Agency for Science, Technology and Research (A*STAR). Singapore.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Salvador, BA, Brasil.
U.S. Food and Drug Administration. Center for Biologics Evaluation and Research. Office of Blood Research and Review. Division of Emerging and Transfusion Transmitted Diseases. Laboratory of Emerging Pathogens. Silver Spring, MD, USA.
Universidad Tecnologica de Pereira. Faculty of Health Sciences. Public Health and Infection Research Group. Pereira, Colombia.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Mosquitos Transmissores de Hematozoários. Rio de Janeiro, RJ, Brasil.
Aix-Marseille Université. Unité des Virus Émergents. Marseille, France / National Institute for Public Health and the Environment. Centre for Infectious Disease Control. Bilthoven, The Netherlands.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Aix-Marseille Université. Unité des Virus Émergents. Marseille, France / Erasmus University Medical Center. Department Viroscience. Rotterdam, The Netherlands.
Stanford University. School of Medicine. Division of Infectious Diseases. Department of Pediatrics. Palo Alto, CA, USA.
National Institute for Public Health and the Environment. Centre for Infectious Disease Control. Bilthoven, The Netherlands / Erasmus University Medical Center. Department Viroscience. Rotterdam, The Netherlands.
Humboldt-Universität zu Berlin. Corporate Member of Freie Universität Berlin. Charité-Universitätsmedizin Berlin. Berlin, Germany / Berlin Institute of Health. Institute of Virology. Berlin, Germany / German Centre for Infection Research. Germany.
University of Texas. Medical Branch. Institute of Human Infection and Immunity. Department of Pathology. Galveston, TX, USA.
Institut Pasteur de Dakar. Unité D'Entomologie Médicale. Dakar, Senegal.
Laveran Military Teaching Hospital. Marseille, France.
Heidelberg University Hospital. Department of Infectious Diseases. Section Clinical Tropical Medicine. Heidelberg, Germany.
Établissement Français Du Sang Alpes Méditerranée. Marseille, France.
Institut Pasteur de Dakar. Unité D'Entomologie Médicale. Dakar, Senegal.
Institut Pasteur. Department of Virology. Arboviruses and Insect Vectors Unit. Paris, France.
University of Texas Medical Branch. Institute for Human Infections and Immunity. Department of Microbiology and Immunology. Galveston, TX, USA.
Aix-Marseille Université. Unité des Virus Émergents. Marseille, France.
Institut Pasteur Du Cambodge. Medical Entomology Platform. Phnom Penh, Cambodia.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Blood Systems Research Institute. San Francisco, CA, USA / University of California. Department of Laboratory Medicine. San Francisco, CA, USA.
Washington University. School of Medicine. Department of Medicine. Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. St. Louis, MO, USA / Washington University. School of Medicine. Department of Molecular Microbiology. Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. St. Louis, MO, USA / Washington University. School of Medicine. Department of Pathology and Immunology. Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. St. Louis, MO, USA.
Public Health Agency of Canada. National Microbiology Laboratory. Zoonotic Diseases and Special Pathogens. Winnipeg, Canada.
Medical Research Council. University of Glasgow. Centre for Virus Research. Glasgow, UK.
Institut Pasteur. Biology of Infection Unit. Inserm U1117. Paris Descartes University. Departement of Infectious Diseases and Tropical Medicine. Necker-Enfants Malades University Hospital. APHP. IHU Imagine. Paris, France.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Mosquitos Transmissores de Hematozoários. Rio de Janeiro, RJ, Brasil.
Katholieke Universiteit Leuven. Rega Institute for Medical Research. Department of Microbiology and Immunology. Laboratory of Virology and Chemotherapy. Leuven, Belgium.
Singapore Immunology Network. Agency for Science, Technology and Research (A*STAR). Singapore.
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Salvador, BA, Brasil.
U.S. Food and Drug Administration. Center for Biologics Evaluation and Research. Office of Blood Research and Review. Division of Emerging and Transfusion Transmitted Diseases. Laboratory of Emerging Pathogens. Silver Spring, MD, USA.
Universidad Tecnologica de Pereira. Faculty of Health Sciences. Public Health and Infection Research Group. Pereira, Colombia.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Mosquitos Transmissores de Hematozoários. Rio de Janeiro, RJ, Brasil.
Aix-Marseille Université. Unité des Virus Émergents. Marseille, France / National Institute for Public Health and the Environment. Centre for Infectious Disease Control. Bilthoven, The Netherlands.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Aix-Marseille Université. Unité des Virus Émergents. Marseille, France / Erasmus University Medical Center. Department Viroscience. Rotterdam, The Netherlands.
Abstract
The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) chikungunya (CHIKV), o'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group has been established to identify gaps of knowledge about the natural history, epidemiology and medical management of infection by these viruses, and to provide adapted recommendations for future investigations. Here, we present a report dedicated to ONNV epidemiological distribution. Two large-scale ONNV outbreaks have been identified in Africa in the last 60 years, interspersed with sporadic serosurveys and case reports of returning travelers. The assessment of the real scale of ONNV circulation in Africa remains a difficult task and surveillance studies are necessary to fill this gap. The identification of ONNV etiology is made complicated by the absence of multiplex tools in co-circulation areas and that of reference standards, as well as the high cross-reactivity with related pathogens observed in serological tests, in particular with CHIKV. This is a specific obstacle for seroprevalence studies, that necessitate an improvement of serological tools to provide robust results. The scarcity of existent genetic data currently limits molecular epidemiology studies. ONNV epidemiology would also benefit from reinforced entomological and environmental surveillance. Finally, the natural history of the disease deserves to be further investigated, with a specific attention paid to long-term complications. Considering our incomplete knowledge on ONNV distribution, GloPID-R CHIKV, ONNV and MAYV experts recommend that a major effort should be done to fill existing gaps.
Keywords in Portuguese
Virus ChikungunyaO'nyong-nyong Virus
História Natural das Doenças
Soroprevalência
Epidemiologia
Keywords
Chikungunya virusO'nyong-nyong Virus
Natural History of Diseases
Soroprevalence
Epidemiology
Share